<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=": Research Article : Medicine and Health Sciences : Epidemiology:" exact="Infectious" post="Disease Epidemiology : Medicine and Health Sciences : Medical"/>
 <result pre="Research Article : Medicine and Health Sciences : Epidemiology: Infectious" exact="Disease" post="Epidemiology : Medicine and Health Sciences : Medical Conditions"/>
 <result pre="Epidemiology : Medicine and Health Sciences : Medical Conditions :" exact="Infectious" post="Diseases: Infectious Disease Epidemiology : Medicine and Health Sciences"/>
 <result pre="Medicine and Health Sciences : Medical Conditions : Infectious Diseases:" exact="Infectious" post="Disease Epidemiology : Medicine and Health Sciences : Medical"/>
 <result pre="and Health Sciences : Medical Conditions : Infectious Diseases: Infectious" exact="Disease" post="Epidemiology : Medicine and Health Sciences : Medical Conditions"/>
 <result pre="Epidemiology : Medicine and Health Sciences : Medical Conditions :" exact="Infectious" post="Diseases: Respiratory Infections : Medicine and Health Sciences :"/>
 <result pre="Medicine and Health Sciences : Medical Conditions : Infectious Diseases:" exact="Respiratory" post="Infections : Medicine and Health Sciences : Medical Conditions"/>
 <result pre="and Health Sciences : Medical Conditions : Infectious Diseases: Respiratory" exact="Infections" post=": Medicine and Health Sciences : Medical Conditions :"/>
 <result pre="Infections : Medicine and Health Sciences : Medical Conditions :" exact="Respiratory" post="Disorders: Respiratory Infections : Medicine and Health Sciences :"/>
 <result pre="Medicine and Health Sciences : Medical Conditions : Respiratory Disorders:" exact="Respiratory" post="Infections : Medicine and Health Sciences : Pulmonology :"/>
 <result pre="and Health Sciences : Medical Conditions : Respiratory Disorders: Respiratory" exact="Infections" post=": Medicine and Health Sciences : Pulmonology : Respiratory"/>
 <result pre="Respiratory Infections : Medicine and Health Sciences : Pulmonology :" exact="Respiratory" post="Disorders: Respiratory Infections : Biology and life sciences :"/>
 <result pre=": Medicine and Health Sciences : Pulmonology : Respiratory Disorders:" exact="Respiratory" post="Infections : Biology and life sciences : Organisms :"/>
 <result pre="Medicine and Health Sciences : Pulmonology : Respiratory Disorders: Respiratory" exact="Infections" post=": Biology and life sciences : Organisms : Viruses"/>
 <result pre="sciences : Microbiology : Medical microbiology : Microbial pathogens :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
 <result pre="Pathology and laboratory medicine : Pathogens : Microbial pathogens :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
 <result pre=": Biology and life sciences : Organisms : Viruses :" exact="Viral" post="pathogens : Coronaviruses : SARS coronavirus: SARS CoV 2"/>
 <result pre="Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar[2]," exact="Infectious" post="Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar"/>
 <result pre="of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar[2], Infectious" exact="Disease" post="Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation"/>
 <result pre="Education City, Doha, Qatar[3], World Health Organization Collaborating Centre for" exact="Disease" post="Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral"/>
 <result pre="for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and" exact="Viral" post="Hepatitis, Weill Cornell Medicine â€&quot; Qatar, Cornell University, Qatar"/>
 <result pre="United States of America[5], Department of Epidemiology and Population Health," exact="American" post="University of Beirut, Beirut, LebanonSartoriusBennEditor[], University of KwaZulu-Natal School"/>
 <result pre="source are credited.pone.0237959.pdf Abstract Current geographic spread of documented severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) infections shows heterogeneity. This"/>
 <result pre="are credited.pone.0237959.pdf Abstract Current geographic spread of documented severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) infections shows heterogeneity. This study"/>
 <result pre="credited.pone.0237959.pdf Abstract Current geographic spread of documented severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) infections shows heterogeneity. This study explores"/>
 <result pre="spread of documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" exact="infections" post="shows heterogeneity. This study explores the role of age"/>
 <result pre="explores the role of age in potentially driving differentials in" exact="infection" post="spread, epidemic potential, and rates of disease severity and"/>
 <result pre="driving differentials in infection spread, epidemic potential, and rates of" exact="disease" post="severity and mortality across countries. An age-stratified deterministic mathematical"/>
 <result pre="in the distribution of the population by age. In the" exact="African" post="Region (median age: 18.9 years), the median R0 was"/>
 <result pre="and the median (per 100 persons) for the final cumulative" exact="infection" post="incidence was 22.5 (versus 69.0), for severe and/or critical"/>
 <result pre="infection incidence was 22.5 (versus 69.0), for severe and/or critical" exact="disease" post="cases rate was 3.3 (versus 13.0), and for death"/>
 <result pre="driver of variable SARS-CoV-2 epidemic trajectories worldwide. Countries with sizable" exact="adult" post="and/or elderly populations and smaller children populations may experience"/>
 <result pre="smaller children populations may experience large and rapid epidemics in" exact="absence of" post="interventions. Meanwhile, countries with predominantly younger age cohorts may"/>
 <result pre="https://github.com/HousseinAyoub/COVID-19-Code.git. Introduction The current geographic spread of the documented severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) [1] infections and associated"/>
 <result pre="Introduction The current geographic spread of the documented severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) [1] infections and associated Coronavirus"/>
 <result pre="The current geographic spread of the documented severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) [1] infections and associated Coronavirus Disease"/>
 <result pre="the documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]" exact="infections" post="and associated Coronavirus Disease 2019 (COVID-2019) [1] shows heterogeneity"/>
 <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2) [1] infections and associated Coronavirus" exact="Disease" post="2019 (COVID-2019) [1] shows heterogeneity [2]. This remains unexplained"/>
 <result pre="role of age in explaining the differential spread of the" exact="infection" post="and its future epidemic potential. As our understanding of"/>
 <result pre="[3], the role of age in the epidemiology of this" exact="infection" post="is becoming increasingly apparent [4â€&quot;7]. In a recent study"/>
 <result pre="[4], we quantified the effect of age on the biological" exact="susceptibility to" post="infection acquisition. We found that relative to individuals aged"/>
 <result pre="quantified the effect of age on the biological susceptibility to" exact="infection" post="acquisition. We found that relative to individuals aged 60â€&quot;69"/>
 <result pre="assortativeness in population mixing by age [4]. Age also affects" exact="disease" post="progression [7â€&quot;10] and mortality risk [11â€&quot;13] among those infected."/>
 <result pre="and mortality risk [11â€&quot;13] among those infected. The proportion of" exact="infections" post="that eventually progress to severe disease, critical disease, or"/>
 <result pre="the basic reproduction number (R0), epidemic potential, and rates of" exact="disease" post="severity and mortality. R0 is defined here as the"/>
 <result pre="and mortality. R0 is defined here as the number of" exact="infections" post="caused by an index case in a fully susceptible"/>
 <result pre="R0, and the rate per 100 persons (out of the" exact="total" post="population by the end of the epidemic cycle) of"/>
 <result pre="cumulative number of incident infections, mild infections, severe and/or critical" exact="disease" post="cases, and deaths, in addition to the number of"/>
 <result pre="scenario for the epidemic in each country, that is in" exact="absence of" post="any intervention. The model stratified the population into compartments"/>
 <result pre="into compartments according to age (0â€&quot;9, 10â€&quot;19, â€¦, â‰¥80 years)," exact="infection" post="status (uninfected, infected), infection stage (mild, severe, critical), and"/>
 <result pre="age (0â€&quot;9, 10â€&quot;19, â€¦, â‰¥80 years), infection status (uninfected, infected)," exact="infection" post="stage (mild, severe, critical), and disease stage (severe, critical),"/>
 <result pre="infection status (uninfected, infected), infection stage (mild, severe, critical), and" exact="disease" post="stage (severe, critical), using a system of coupled nonlinear"/>
 <result pre="each age group were assumed at risk of acquiring the" exact="infection" post="at a hazard rate that varies based on the"/>
 <result pre="at a hazard rate that varies based on the age-specific" exact="susceptibility to" post="the infection (S1 Fig in S1 File), the infectious"/>
 <result pre="rate that varies based on the age-specific susceptibility to the" exact="infection" post="(S1 Fig in S1 File), the infectious contact rate"/>
 <result pre="susceptibility to the infection (S1 Fig in S1 File), the" exact="infectious" post="contact rate per day, and the transmission mixing matrix"/>
 <result pre="informed by the observed age-specific distribution of cases across these" exact="infection" post="stages in China [8â€&quot;10]. The duration of infectiousness was"/>
 <result pre="days [8, 16, 18, 19] after which individuals with mild" exact="infection" post="recover, while those with severe and critical infection develop,"/>
 <result pre="with mild infection recover, while those with severe and critical" exact="infection" post="develop, respectively, severe and critical disease over a period"/>
 <result pre="with severe and critical infection develop, respectively, severe and critical" exact="disease" post="over a period of 28 days [8] prior to"/>
 <result pre="of 28 days [8] prior to recovery. Individuals with critical" exact="disease" post="have the additional risk of disease mortality, as informed"/>
 <result pre="recovery. Individuals with critical disease have the additional risk of" exact="disease" post="mortality, as informed by the age-stratified disease mortality rate"/>
 <result pre="additional risk of disease mortality, as informed by the age-stratified" exact="disease" post="mortality rate in China [11, 12]. Model parameters were"/>
 <result pre="[4] (S1, S2 Tables in S1 File). Namely, the overall" exact="infectious" post="contact rate, age-specific biological susceptibility profile, and age-specific mortality"/>
 <result pre="Fig 2. The median R0 was 1.05 (range: 0.93â€&quot;1.95) in" exact="African" post="Region (AFRO), 1.45 (range: 0.98â€&quot;1.75) in Eastern Mediterranean Region"/>
 <result pre="0.93â€&quot;1.95) in African Region (AFRO), 1.45 (range: 0.98â€&quot;1.75) in Eastern" exact="Mediterranean" post="Region (EMRO), 1.55 (range: 1.15â€&quot;1.95) in South-East Asia Region"/>
 <result pre="one million, across World Health Organization regions. These are the" exact="African" post="Region (AFRO), Eastern Mediterranean Region (EMRO), South-East Asia Region"/>
 <result pre="Health Organization regions. These are the African Region (AFRO), Eastern" exact="Mediterranean" post="Region (EMRO), South-East Asia Region (SEARO), Region of the"/>
 <result pre="the nine select countries, defined as the cumulative number of" exact="infections" post="by the end of the epidemic cycle out of"/>
 <result pre="by the end of the epidemic cycle out of the" exact="total" post="population, was highest in Italy at 75.5 and lowest"/>
 <result pre="and 49.0 (range: 0.25â€&quot;76.5) globally. Fig 3 Estimates for the" exact="total" post="number of infections and the total number of deaths"/>
 <result pre="0.25â€&quot;76.5) globally. Fig 3 Estimates for the total number of" exact="infections" post="and the total number of deaths per 100 persons"/>
 <result pre="3 Estimates for the total number of infections and the" exact="total" post="number of deaths per 100 persons in select countries."/>
 <result pre="and 1.6 (range: 0.0â€&quot;5.3) globally. The estimated rate of mild" exact="infections" post="per 100 persons in the nine select countries was"/>
 <result pre="and 41.0 (range: 0.25â€&quot;61.5) globally. Fig 4 Estimates for the" exact="total" post="number of mild infections and the total number of"/>
 <result pre="globally. Fig 4 Estimates for the total number of mild" exact="infections" post="and the total number of severe and/or critical diseases"/>
 <result pre="Estimates for the total number of mild infections and the" exact="total" post="number of severe and/or critical diseases cases per 100"/>
 <result pre="select countries. Meanwhile, the estimated rate of severe and/or critical" exact="disease" post="cases per 100 persons in the nine select countries"/>
 <result pre="role of age in driving divergent SARS-CoV-2 epidemic trajectories and" exact="disease" post="burdens. The effect of age reflects the interplay of"/>
 <result pre="susceptibility by age (S1 Fig in S1 File), variation in" exact="disease" post="severity and mortality by age (S2 Fig in S1"/>
 <result pre="stark variations in R0 (Fig 2), and consequently epidemic potential," exact="disease" post="severity, and disease mortalityâ€&quot;there was strong correlation between R0"/>
 <result pre="R0 (Fig 2), and consequently epidemic potential, disease severity, and" exact="disease" post="mortalityâ€&quot;there was strong correlation between R0 and median age"/>
 <result pre="0.19â€&quot;0.47), p&amp;lt;0.001). Although this may be explained by more diagnosed" exact="infections" post="being reported by countries with advanced testing infrastructure, this"/>
 <result pre="may support the role of age presented here. Importantly, as" exact="infection" post="transmission dynamics is a non-linear phenomenon, even small changes"/>
 <result pre="increased R0 from 0.93 to 2.6. This demonstrates how the" exact="lower" post="susceptibility among younger persons, particularly children, acts as a"/>
 <result pre="â€œherd immunityâ€� impeding the ferocious strength of the force of" exact="infection" post="of an otherwise very infectious virus. This epidemiological feature"/>
 <result pre="strength of the force of infection of an otherwise very" exact="infectious" post="virus. This epidemiological feature contrasts that of other respiratory"/>
 <result pre="very infectious virus. This epidemiological feature contrasts that of other" exact="respiratory" post="infections, such as the 2009 influenza A (H1N1) pandemic"/>
 <result pre="infections, such as the 2009 influenza A (H1N1) pandemic (H1N1pdm)" exact="infection" post="(S5 Fig in S1 File) [29], where the cumulative"/>
 <result pre="from the above results is that epidemic size and associated" exact="disease" post="burden could be highest in settings with sizable mid-age"/>
 <result pre="relevance to containment efforts relates to the likelihood of the" exact="infection" post="establishing itself in a population. In addition to the"/>
 <result pre="role of travel patterns/restrictions and multiple introductions for seeding the" exact="infection" post="[30], the probability of a major outbreak upon introduction"/>
 <result pre="the probability of a major outbreak upon introduction of one" exact="infection" post="is given approximately by 1âˆ’1/R0 [31, 32]. Accordingly, in"/>
 <result pre="contacts), age-dependent transmissibility effects, and underlying co-morbidities which also impact" exact="disease" post="severity and mortality [33â€&quot;36]. These factors may have contributed"/>
 <result pre="data. Our estimates were based on SARS-CoV-2 natural history and" exact="disease" post="progression data from China, but these may not be"/>
 <result pre="simply reflect differences in social behavior or the probability of" exact="infection" post="ascertainment. The presence and contribution of such factors are,"/>
 <result pre="the attack rate from different countries supports age heterogeneity and" exact="lower" post="exposure among children, different countries show still variation in"/>
 <result pre="S7 Figs in S1 File). Of note that the observed" exact="lower" post="susceptibility to the infection at younger age [4] does"/>
 <result pre="Figs in S1 File). Of note that the observed lower" exact="susceptibility to" post="the infection at younger age [4] does not necessarily"/>
 <result pre="File). Of note that the observed lower susceptibility to the" exact="infection" post="at younger age [4] does not necessarily imply absence"/>
 <result pre="the infection at younger age [4] does not necessarily imply" exact="absence of" post="infection, but may reflect rapid infection clearance or subclinical"/>
 <result pre="not necessarily imply absence of infection, but may reflect rapid" exact="infection" post="clearance or subclinical infection. This may impact our estimates"/>
 <result pre="in S1 File, respectively). It is conceivable that such subclinical" exact="infections" post="may have lower viral load, and therefore rapid infection"/>
 <result pre="respectively). It is conceivable that such subclinical infections may have" exact="lower" post="viral load, and therefore rapid infection clearance and limited"/>
 <result pre="It is conceivable that such subclinical infections may have lower" exact="viral" post="load, and therefore rapid infection clearance and limited transmission"/>
 <result pre="subclinical infections may have lower viral load, and therefore rapid" exact="infection" post="clearance and limited transmission potential. Data on infection clusters"/>
 <result pre="have lower viral load, and therefore rapid infection clearance and" exact="limited" post="transmission potential. Data on infection clusters from China and"/>
 <result pre="therefore rapid infection clearance and limited transmission potential. Data on" exact="infection" post="clusters from China and other countries suggested that children"/>
 <result pre="to play a significant role in the transmission of this" exact="infection" post="[7, 8, 38]. Increasingly, evidence suggests that R0 is"/>
 <result pre="interventions and associated behavioral changes [41]. There could be also" exact="transient" post="effects affecting transmission patterns and epidemic dynamics [41, 42]."/>
 <result pre="(S10 Fig in S1 File). Our study may have overestimated" exact="disease" post="mortality by basing mortality rates on estimates of the"/>
 <result pre="analysis. The latter may have biased our reported results towards" exact="lower" post="R0. For instance, the most probable value for R0"/>
 <result pre="driver of variable SARS-CoV-2 epidemic trajectories worldwide. Countries with sizable" exact="adult" post="and/or elderly populations and smaller children populations may experience"/>
 <result pre="smaller children populations may experience large and rapid epidemics in" exact="absence of" post="interventions, necessitating disruptive social distancing measures to contain the"/>
 <result pre="prevention interventions, as although many countries are predicted to have" exact="lower" post="R0, these also often coincide with those having limited"/>
 <result pre="have lower R0, these also often coincide with those having" exact="limited" post="healthcare capacity and testing. Once established, and even if"/>
 <result pre="file. References References 1World Health Organization (WHO). Naming the coronavirus" exact="disease" post="(COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed"/>
 <result pre="Age specificity of cases and attack rate of novel coronavirus" exact="disease" post="(COVID-19). medRxiv. 2020:2020.03.09.20033142. 10.1101/2020.03.09.20033142 7DaviesNG, KlepacP, LiuY, PremK, JitM,"/>
 <result pre="Med. 202010.1038/s41591-020-0962-9 .32546824 8World Health Organization. Report of the WHO-China" exact="Joint" post="Mission on Coronavirus Disease 2019 (COVID-19). https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed on"/>
 <result pre="Health Organization. Report of the WHO-China Joint Mission on Coronavirus" exact="Disease" post="2019 (COVID-19). https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed on March 10, 2020. 2020."/>
 <result pre="NiZY, HuY, LiangWH, OuCQ, HeJX, et al.Clinical Characteristics of Coronavirus" exact="Disease" post="2019 in China. N Engl J Med. 202010.1056/NEJMoa2002032 .32109013"/>
 <result pre="in Wuhan, China. Lancet. 2020;395(10223):497â€&quot;506. 10.1016/S0140-6736(20)30183-5 .31986264 11collab: Novel Coronavirus" exact="Pneumonia" post="Emergency Response Epidemiology Team. [The epidemiological characteristics of an"/>
 <result pre="12WuZ, McGooganJM. Characteristics of and Important Lessons From the Coronavirus" exact="Disease" post="2019 (COVID-19) Outbreak in China: Summary of a Report"/>
 <result pre="a Report of 72314 Cases From the Chinese Center for" exact="Disease" post="Control and Prevention. JAMA. 202010.1001/jama.2020.2648 .32091533 13VerityR., OkellL.C., DorigattiI.,"/>
 <result pre="WinskillP., WhittakerC., ImaiN., et al.Estimates of the severity of coronavirus" exact="disease" post="2019: a model-based analysis. The Lancet. 2020;20:30243â€&quot;7. 10.1016/S1473-3099(20)30243-7. 14DelamaterPL,"/>
 <result pre="2020. 16LiR, PeiS, ChenB, SongY, ZhangT, YangW, et al.Substantial undocumented" exact="infection" post="facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science."/>
 <result pre="BiQ, JonesFK, ZhengQ, MeredithHR, et al.The Incubation Period of Coronavirus" exact="Disease" post="2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and"/>
 <result pre="10.7326/M20-0504 .32150748 18ZouL, RuanF, HuangM, LiangL, HuangH, HongZ, et al.SARS-CoV-2" exact="Viral" post="Load in Upper Respiratory Specimens of Infected Patients. N"/>
 <result pre="HuangM, LiangL, HuangH, HongZ, et al.SARS-CoV-2 Viral Load in Upper" exact="Respiratory" post="Specimens of Infected Patients. N Engl J Med. 2020;382(12):1177â€&quot;9."/>
 <result pre="19RotheC, SchunkM, SothmannP, BretzelG, FroeschlG, WallrauchC, et al.Transmission of 2019-nCoV" exact="Infection" post="from an Asymptomatic Contact in Germany. N Engl J"/>
 <result pre="1997;145(12):1127â€&quot;37. 10.1093/oxfordjournals.aje.a0090769199543 22AyoubHH, ChemaitellyH, Abu-RaddadLJ. Characterizing the transitioning epidemiology of" exact="herpes" post="simplex virus type 1 in the USA: model-based predictions."/>
 <result pre="ChemaitellyH, Abu-RaddadLJ. Characterizing the transitioning epidemiology of herpes simplex virus" exact="type 1" post="in the USA: model-based predictions. BMC Med. 2019;17(1):5710.1186/s12916-019-1285-x30853029 23AwadSF,"/>
 <result pre=".24593916 25ChemaitellyH, AwadSF, SheltonJD, Abu-RaddadLJ. Sources of HIV incidence among" exact="stable" post="couples in sub-Saharan Africa. J Int AIDS Soc. 2014;17:1876510.7448/IAS.17.1.1876524560339"/>
 <result pre="Int AIDS Soc. 2014;17:1876510.7448/IAS.17.1.1876524560339 26AyoubHH, Abu-RaddadLJ. Impact of treatment on" exact="hepatitis C" post="virus transmission and incidence in Egypt: A case for"/>
 <result pre="incidence in Egypt: A case for treatment as prevention. J" exact="Viral" post="Hepat. 2017;24(6):486â€&quot;95. 10.1111/jvh.12671 .28039923 27MATLABÂ®. The Language of Technical"/>
 <result pre="PullanoG, PinottiF, ValdanoE, PolettoC, BoellePY, et al.Preparedness and vulnerability of" exact="African" post="countries against importations of COVID-19: a modelling study. Lancet."/>
 <result pre="al.Social contacts and mixing patterns relevant to the spread of" exact="infectious diseases." post="Plos Med. 2008;5(3):381â€&quot;91. 10.1371/journal.pmed.005007418366252 35PremK, CookAR, JitM. Projecting social"/>
 <result pre="the proportion of younger adults and older adolescents among coronavirus" exact="disease" post="(COVID-19) cases following the introduction of physical distancing measures,"/>
 <result pre="TongZWM, SteeleLE, et al.Children are unlikely to have been the" exact="primary" post="source of household SARS-CoV-2 infections. medRxiv. 2020:2020.03.26.20044826. 10.1101/2020.03.26.20044826 39HeW,"/>
 <result pre="Estimation of the basic reproduction number, average incubation time, asymptomatic" exact="infection" post="rate, and case fatality rate for COVID-19: Meta-analysis and"/>
</results>
